Princeton, NJ (January 27, 2010) – PeriGen, Inc., the only OB-specific risk reduction company to provide solutions which generate immediate quantifiable clinical and financial value, today announced that it has received an equity investment from Salmon River Capital, LLC. The New York-based private equity and venture capital firm specializes in building technology-enabled enterprises in select industries, which include healthcare information technology, education/training, financial services technologies, online media, and information utilities.
“At Salmon River, we have a single objective: to work in active partnership with entrepreneurial teams to build exceptional technology-enabled enterprises across a set of industries we know well,” said Joshua Lewis, Founder and Managing Principal of Salmon River Capital. “We know the healthcare IT sector quite well, and we recognize that PeriGen is poised to become an industry- leader."
PeriGen provides unique technology-enabled risk reduction solutions for Obstetrics. With a compliment of consulting and professional services, PeriGen’s patented clinical decision support and fetal monitoring solutions evaluate patient data against 6,500 OB-specific clinical guidelines and protocols to generate real- time prompts, alerts, and reminders at the patient’s bedside. Providing a virtual “safety net” for both patients and clinicians, PeriGen helps to ensure the early identification of potential problems, leading to swift intervention and better clinical outcomes. PeriGen’s proprietary reporting and analytics tools quantify the improvements, and furnish hospitals with the data needed to drive a cycle of continuous improvement.“In 2009, we established several strategic partnerships with companies that shared our vision for the advancement of perinatal care through improved quality and patient safety,” said Donald A. Deieso, PhD, Chairman and CEO, PeriGen, Inc. “We are proud to count Salmon River Capital among them. Our partnership with Salmon River not only represents an opportunity for continued growth for PeriGen, but the opportunity for us to work with focused and dedicated individuals who recognize the innovation of our technology, and who appreciate the impact that our solutions will have on the industry.”
In addition to Salmon River’s equity investment, PeriGen benefits from the continued support of its existing investors, Galen Partners and Trident Capital. In July of 2009, PeriGen acquired the software and related assets of Montreal- based LMS Medical Systems, uniting two leaders in technology-enabled OB-risk reduction. By integrating LMS’s suite of advanced fetal strip monitoring and interpretative solutions with PeriGen’s advanced clinical decision support, PeriGen now provides hospitals with the most comprehensive OB decision support and documentation solution available.
About PeriGen, Inc.
Formerly E&C Medical Intelligence, PeriGen is a technology-enabled professional services company specializing in risk reduction and clinical quality improvement in Obstetrics. Singularly focused on reducing risk and improving financial performance, PeriGen’s clinical decision support and fetal monitoring solutions are installed in over 100 hospitals across North America. A pioneer in clinical decision support, PeriGen provides innovative solutions and a full suite of complementary professional and consulting services that reduce risk and improve clinical outcomes. PeriGen is a US corporation headquartered in Princeton, New Jersey, with offices in Canada and Israel. For more information, please visit us at www.perigen.com.
About Salmon River Capital, LLC
Salmon River Capital is a specialized private equity and venture capital firm. We are both entrepreneurs and experienced venture capital/private equity investors. We focus our energy and capital on a limited number of entrepreneurial teams committed to building exceptional technology-enabled enterprises in a select set of industries we know well. These verticals include health care information technology, education/training, financial services technologies, online media, and information utilities. We leverage a broad set of capabilities, an unusually flexible capital base, and a long time horizon. For more information, please visit us at www.salmonrivercapital.com.
Download print-friendly version (PDF)
Contact: Adrienne Kowalski (215) 790-7839 Cell : (215) 850-4641 adrienne@karmaverse.com
Sandra Taylor, Ph.D. Chief Marketing Officer (609) 228-8346 STaylor@perigen.com
>
